These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35664370)

  • 21. Structural Brain Abnormalities of Attention-Deficit/Hyperactivity Disorder With Oppositional Defiant Disorder.
    Noordermeer SDS; Luman M; Greven CU; Veroude K; Faraone SV; Hartman CA; Hoekstra PJ; Franke B; Buitelaar JK; Heslenfeld DJ; Oosterlaan J
    Biol Psychiatry; 2017 Nov; 82(9):642-650. PubMed ID: 28911901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms of conduct disorder, oppositional defiant disorder, attention-deficit/hyperactivity disorder, and callous-unemotional traits as unique predictors of psychosocial maladjustment in boys: advancing an evidence base for DSM-V.
    Pardini DA; Fite PJ
    J Am Acad Child Adolesc Psychiatry; 2010 Nov; 49(11):1134-44. PubMed ID: 20970701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social Skills Training in Children With Attention Deficit Hyperactivity Disorder: A Randomized-Controlled Clinical Trial.
    Antshel KM; Remer R
    J Clin Child Adolesc Psychol; 2003; 32(1):152-165. PubMed ID: 12573940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative outcomes in attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Ayaz AB; Ayaz M; Kayan E
    Ir J Psychol Med; 2015 Dec; 32(4):307-312. PubMed ID: 30185252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder.
    Connor DF; Steeber J; McBurnett K
    J Dev Behav Pediatr; 2010 Jun; 31(5):427-40. PubMed ID: 20535081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trajectories of attention deficit hyperactivity disorder and oppositional defiant disorder symptoms as precursors of borderline personality disorder symptoms in adolescent girls.
    Stepp SD; Burke JD; Hipwell AE; Loeber R
    J Abnorm Child Psychol; 2012 Jan; 40(1):7-20. PubMed ID: 21671009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Efficacy of a Mindfulness Program for Boys With Attention-Deficit Hyperactivity Disorder and Oppositional Defiant Disorder.
    Muratori P; Conversano C; Levantini V; Masi G; Milone A; Villani S; Bögels S; Gemignani A
    J Atten Disord; 2021 Sep; 25(11):1544-1553. PubMed ID: 32338110
    [No Abstract]   [Full Text] [Related]  

  • 29. The longitudinal course of comorbid oppositional defiant disorder in girls with attention-deficit/hyperactivity disorder: findings from a controlled 5-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Monuteaux MC; Mick E; Parcell T; Westerberg D; Faraone SV
    J Dev Behav Pediatr; 2008 Dec; 29(6):501-7. PubMed ID: 19077845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder.
    Kutlu A; Akyol Ardic U; Ercan ES
    J Clin Psychopharmacol; 2017 Apr; 37(2):220-225. PubMed ID: 28225747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children.
    Kadesjö C; Hägglöf B; Kadesjö B; Gillberg C
    Dev Med Child Neurol; 2003 Oct; 45(10):693-9. PubMed ID: 14515941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder.
    Rhodes SM; Park J; Seth S; Coghill DR
    J Child Psychol Psychiatry; 2012 Feb; 53(2):128-37. PubMed ID: 21770938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.
    Tzang RF; Chang YC; Tsai GE; Lane HY
    J Psychopharmacol; 2016 Oct; 30(10):976-82. PubMed ID: 27443598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Disruptive Behavior Disorders on Academic Performance and School Functions of Youths with Attention-Deficit/Hyperactivity Disorder.
    Liu CY; Huang WL; Kao WC; Gau SS
    Child Psychiatry Hum Dev; 2017 Dec; 48(6):870-880. PubMed ID: 28168530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
    J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory Control Deficits in Children with Oppositional Defiant Disorder and Conduct Disorder Compared to Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis.
    Bonham MD; Shanley DC; Waters AM; Elvin OM
    Res Child Adolesc Psychopathol; 2021 Jan; 49(1):39-62. PubMed ID: 33048265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
    Gadow KD; Arnold LE; Molina BS; Findling RL; Bukstein OG; Brown NV; McNamara NK; Rundberg-Rivera EV; Li X; Kipp HL; Schneider J; Farmer CA; Baker JL; Sprafkin J; Rice RR; Bangalore SS; Butter EM; Buchan-Page KA; Hurt EA; Austin AB; Grondhuis SN; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):948-959.e1. PubMed ID: 25151418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical precursors of adolescent conduct disorder in children with attention-deficit/hyperactivity disorder.
    Whittinger NS; Langley K; Fowler TA; Thomas HV; Thapar A
    J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):179-87. PubMed ID: 17242621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
    Kaplan S; Heiligenstein J; West S; Busner J; Harder D; Dittmann R; Casat C; Wernicke JF
    J Atten Disord; 2004 Oct; 8(2):45-52. PubMed ID: 15801334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.